PROSCA & BLADDR 2023
PROSCA
PROSCA & BLADDR 2023
PCaGoal: Prostate Cancer Patients Football Team at FC Porto
FEATURING
Diogo Nunes-Carneiro
- 7 views
- January 18, 2024
PROSCA & BLADDR 2023
The Power of Play: Enhancing Patients’ Health and Well-Being Through Team Sports
FEATURING
Susana PóVoas
- 9 views
- January 18, 2024
PROSCA & BLADDR 2023
Radioligand Therapy for Prostate Cancer: For Whom and When
FEATURING
Ken Herrmann
- 82 views
- January 16, 2024
- 1
PROSCA & BLADDR 2023
Updates on PARPi in Prostate Cancer
FEATURING
Elena Castro
- 67 views
- January 16, 2024
PROSCA & BLADDR 2023
Liquid Biopsy as a Treatment Selector in mCRPC
FEATURING
Bram De Laere
- 33 views
- January 16, 2024
PROSCA & BLADDR 2023
Improving Psychological Well-Being of Advanced Prostate Cancer Patients
FEATURING
Tania Estapé
- 22 views
- January 16, 2024
PROSCA & BLADDR 2023
QoL in Patients With Advanced Prostate Cancer Who Are Living Longer: Managing Cognitive Changes
FEATURING
Daniele Raggi
- 52 views
- January 16, 2024
PROSCA & BLADDR 2023
Lifestyle & Prevention of Complications in Advanced Prostate Cancer: Insights From APCCC
FEATURING
Aurelius Omlin
- 29 views
- January 16, 2024
PROSCA & BLADDR 2023
De-Escalating Strategies in HSPC
FEATURING
Bertrand Tombal
- 22 views
- January 16, 2024
PROSCA & BLADDR 2023
How Should Prostate Cancer Be Diagnosed: Targeted Biopsies Alone Should Be the Standard of Care
FEATURING
Johan Stranne
- 10 views
- January 16, 2024
PROSCA & BLADDR 2023
How Should Prostate Cancer Be Diagnosed: Targeted + Systematic Biopsy
FEATURING
Roderick van den Bergh
- 82 views
- January 16, 2024
PROSCA & BLADDR 2023
Local Treatment of the Prostate in Synchronous mHSPC
FEATURING
Alberto Bossi
- 136 views
- January 12, 2024
- 1
PROSCA & BLADDR 2023
Treatment Intensification of High-Risk BCR Prostate Cancer
FEATURING
Antti Rannikko
- 86 views
- January 12, 2024
PROSCA & BLADDR 2023
Systemic Therapy in mHSPC: Who Needs Treatment Intensification?
FEATURING
Amit Bahl
- 109 views
- January 12, 2024
- 1
PROSCA & BLADDR 2023
Clinical Implications of Genomic Alterations in Prostate Cancer
FEATURING
David Olmos
- 101 views
- January 12, 2024
- 1
PROSCA & BLADDR 2023
Is Metastasis-Directed Therapy for Prostate Cancer Still Experimental?
FEATURING
Thomas Zilli
- 91 views
- January 12, 2024
PROSCA & BLADDR 2023
Nodal Recurrences in Prostate Cancer: What Is the Optimal Approach?
FEATURING
Piet Ost
- 185 views
- January 12, 2024
PROSCA & BLADDR 2023
When Is RT Indicated for Prostate Cancer and Should We Add ADT?
FEATURING
Paul Sargos
- 177 views
- January 12, 2024
- 1
PROSCA & BLADDR 2023
Innovations in Nerve Sparing Robotic Prostatectomy
FEATURING
Ashutosh Tewari
- 20 views
- January 12, 2024
PROSCA & BLADDR 2023
Intermediate to High-Risk Prostate Cancer: Who Needs Treatment Intensification?
FEATURING
Piet Ost
- 99 views
- January 12, 2024
PROSCA & BLADDR 2023
Should Extended LND Still Be SOC for High-Risk Prostate Cancer?
FEATURING
Jochen Walz
- 66 views
- January 12, 2024
PROSCA & BLADDR 2023
Translating New Data Into Clinical Practice: The Mirrors of Medicine Way
FEATURING
Herman Stoevelaar
- 5 views
- January 12, 2024
PROSCA & BLADDR 2023
Prostate Cancer Screening and Organized Testing
FEATURING
Antti Rannikko
- 103 views
- January 12, 2024
PROSCA & BLADDR 2023
The Role of PSMA-PET/CT in Primary Staging, for Follow-Up After Radical Treatment and for Advanced Prostate Cancer
FEATURING
Karolien Goffin
- 192 views
- January 12, 2024
- 1